Neue morphologische und molekulare Aspekte des Lungenkarzinoms

Molekulare Diagnostik in der Pathologie

(2013) A. Stenzinger et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

MET As a Possible Target for Non–Small-Cell Lung Cancer

(2013) Ahad A. Sadiq et al.   JOURNAL OF CLINICAL ONCOLOGY

ERCC1 and RRM1: Ready for Prime Time?

(2013) Benjamin Besse et al.   JOURNAL OF CLINICAL ONCOLOGY

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor–Resistant Disease

(2013) Kadoaki Ohashi et al.   JOURNAL OF CLINICAL ONCOLOGY

ALKin Lung Cancer: Past, Present, and Future

(2013) Alice T. Shaw et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Diagnostic Profiling of Lung Cancer Specimens with a Semiconductor-Based Massive Parallel Sequencing Approach

(2013) Volker Endris et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

(2013) Prudence A. Russell et al.   Journal of Thoracic Oncology

Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib

(2013) M. Bos et al.   LUNG CANCER

Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids

(2013) Arne Warth et al.   VIRCHOWS ARCHIV

Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact

(2012) William Sterlacci et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

(2012) Marcin Imielinski et al.   CELL

The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma

(2012) T. Murakawa et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer

(2012) Tatsuo Maeyashiki et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma

(2012) Mathieu Lederlin et al.   EUROPEAN RESPIRATORY JOURNAL

Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas

(2012) Arne Warth et al.   EUROPEAN RESPIRATORY JOURNAL

Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non-small-cell lung cancer

(2012) Esther Herpel et al.   HISTOPATHOLOGY

Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies

(2012) Arne Warth et al.   HISTOPATHOLOGY

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

(2012) Arne Warth et al.   JOURNAL OF CLINICAL ONCOLOGY

Stromal invasion and micropapillary pattern in 212 consecutive surgically resected stage I lung adenocarcinomas: histopathological categories for prognosis prediction

(2012) Yi-Chen Yeh et al.   JOURNAL OF CLINICAL PATHOLOGY

Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma

(2012) Jie Gu et al.   JOURNAL OF SURGICAL ONCOLOGY

A Novel EML4-ALK Variant: Exon 6 of EML4 Fused to Exon 19 of ALK

(2012) Roland Penzel et al.   Journal of Thoracic Oncology

Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients

(2012) Akihiko Yoshizawa et al.   Journal of Thoracic Oncology

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

(2012) D Ross Camidge et al.   LANCET ONCOLOGY

Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy

(2012) Alexander Drilon et al.   LANCET ONCOLOGY

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

(2012) Erik Thunnissen et al.   MODERN PATHOLOGY

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma

(2012) Natasha Rekhtman et al.   MODERN PATHOLOGY

Comprehensive genomic characterization of squamous cell lung cancers

(2012)   NATURE

KIF5B-RET fusions in lung adenocarcinoma

(2012) Takashi Kohno et al.   NATURE MEDICINE

Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach

(2012) Tina Zahel et al.   VIRCHOWS ARCHIV

Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies

(2012) Arne Warth et al.   VIRCHOWS ARCHIV

Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification

(2012) Arne Warth et al.   VIRCHOWS ARCHIV

Histopathologic Characteristics of Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification

(2011) Hyo Sup Shim et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome

(2011) Luisa M. Solis et al.   CANCER

Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy

(2011) Arne Warth et al.   EUROPEAN RESPIRATORY JOURNAL

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

(2011) Masahiro Fukuoka et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations

(2011) Antonio Marchetti et al.   JOURNAL OF CLINICAL ONCOLOGY

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

(2011) Prudence A. Russell et al.   Journal of Thoracic Oncology

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

The Role of Irreversible HER Family Inhibition in the Treatment of Patients with Non-Small Cell Lung Cancer

(2011) E. Kwak   ONCOLOGIST

Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

(2011) Peter S. Hammerman et al.   Cancer Discovery

A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

(2010) Gabriel Sica et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

(2010) William D. Travis et al.   Journal of Thoracic Oncology

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

(2010) Robert Pirker et al.   Journal of Thoracic Oncology

S100-Protein-positive Sustentakularzellen in pulmonalen Karzinoiden und thorakalen Paragangliomen

(2010) A. Warth et al.   PATHOLOGE

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

(2010) J. Weiss et al.   Science Translational Medicine

EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC

(2010) Roland Penzel et al.   VIRCHOWS ARCHIV

Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential

(2009) Arne Warth et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM Classification based on recommendations of the IASLC Staging Committee

(2009) William D Travis   HISTOPATHOLOGY